Drug intelligence / Profile preview

thiorphan

Development stage
Preclinical
Lead developer
Roques
Modality
Small Molecules
Administration
Oral, Intravenous (experimental)
01

Overview

Thiorphan is a potent small molecule inhibitor of membrane metalloendopeptidase (enkephalinase, also known as neprilysin). It was the first synthetic enkephalinase inhibitor developed and displays antinociceptive activity after systemic administration. Thiorphan potentiates morphine-induced analgesia and attenuates naloxone-precipitated withdrawal symptoms. It also inhibits angiotensin-converting enzyme to a lesser extent. Thiorphan has been shown to reduce castor oil-induced diarrhea in animal models when administered intravenously but not intracerebroventricularly. In clinical use, thiorphan is the active metabolite of racecadotril (acetorphan), an antidiarrheal medication that acts by inhibiting enkephalinases in the gut to reduce pathological secretion without affecting gastrointestinal motility[1][2][4][5][6][7][10]. Experimental studies suggest neuroprotective effects against excitotoxic brain injury[8].

Other names
dl-thiorphan
02

Targets

ACE (Angiotensin Converting Enzyme)NEP (Neutral Endopeptidase)

Beyond the preview

Go deeper on thiorphan.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on thiorphan.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call